Work

Figure S11 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone

Year: 2024

Type: other

Abstract: In vivo efficacy of TKIs in VHL- RENCA model over 20 days. A, B) Response to TKIs in bone (A) and lung (B) tumors detected by bioluminescence, mean + SEM, n = 8 to 16/group.

DOI: 10.1158/2767-9764.27187292

Authors: Stefan Maksimovic, Nina C. Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I. Pesquera, Wenjiao Li, Jianfeng Chen, Javier A. Gomez, Akshay Basi, Jared K. Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T. Campbell, Eleonora Dondossola

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403227147

Cites:

Cited by:

Related to: 10